Since being founded in 1994, Alexandria Venture Investments continues to invest in companies that are in their seed, early, and growth stages. With strong cash flow and an investment-grade balance sheet, they capitalize on the long-term potential of the life science industry. It has a total market capitalization of $22.2 billion as of June 30, 2019. They look to invest in companies that focus on innovation in life sciences, technology, agetch, and diagnostics.
They strive to accelerate the world’s leading investors in their pursuit of advancing human health by curing disease and improving nutrition. Alexandria Venture Investments was ranked the #1 venture capital investor in the healthcare sector by Forbes in 2018. Their team is focused on providing investment capital to innovative life science and technology entities through Alexandria Venture Investments, our strategic venture capital arm. They also have a capital arm called Alexandria Real Estate Equities, Inc., which is an S&P 500 company. Alexandria Venture Investments is established in locations including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle Park.